全文获取类型
收费全文 | 9623篇 |
免费 | 536篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 131篇 |
儿科学 | 629篇 |
妇产科学 | 143篇 |
基础医学 | 862篇 |
口腔科学 | 194篇 |
临床医学 | 781篇 |
内科学 | 2631篇 |
皮肤病学 | 254篇 |
神经病学 | 516篇 |
特种医学 | 241篇 |
外科学 | 1326篇 |
综合类 | 207篇 |
预防医学 | 417篇 |
眼科学 | 357篇 |
药学 | 580篇 |
中国医学 | 18篇 |
肿瘤学 | 895篇 |
出版年
2023年 | 46篇 |
2022年 | 96篇 |
2021年 | 321篇 |
2020年 | 151篇 |
2019年 | 207篇 |
2018年 | 300篇 |
2017年 | 175篇 |
2016年 | 178篇 |
2015年 | 205篇 |
2014年 | 320篇 |
2013年 | 383篇 |
2012年 | 578篇 |
2011年 | 584篇 |
2010年 | 329篇 |
2009年 | 237篇 |
2008年 | 443篇 |
2007年 | 503篇 |
2006年 | 470篇 |
2005年 | 419篇 |
2004年 | 415篇 |
2003年 | 340篇 |
2002年 | 332篇 |
2001年 | 267篇 |
2000年 | 239篇 |
1999年 | 217篇 |
1998年 | 101篇 |
1997年 | 54篇 |
1996年 | 47篇 |
1995年 | 63篇 |
1993年 | 43篇 |
1992年 | 168篇 |
1991年 | 172篇 |
1990年 | 169篇 |
1989年 | 151篇 |
1988年 | 141篇 |
1987年 | 129篇 |
1986年 | 112篇 |
1985年 | 106篇 |
1984年 | 105篇 |
1983年 | 74篇 |
1982年 | 51篇 |
1981年 | 42篇 |
1980年 | 39篇 |
1979年 | 84篇 |
1978年 | 40篇 |
1977年 | 62篇 |
1974年 | 49篇 |
1972年 | 48篇 |
1970年 | 43篇 |
1969年 | 38篇 |
排序方式: 共有10000条查询结果,搜索用时 656 毫秒
41.
Z A Arlin T Ahmed A Mittelman E Feldman R Mehta P Weinstein E Rieber P Sullivan P Baskind 《Journal of clinical oncology》1987,5(3):371-375
Amsacrine and high-dose cytarabine (HiDAc), when administered as single agents, are effective treatment of acute leukemia. When used in combination, a high remission rate is also possible. We treated 47 patients with acute myelogenous leukemia (AML), acute lymphoblastic leukemia (ALL), and blastic phase of chronic myelogenous leukemia (CML) with a combination of amsacrine and HiDAc. The patients received amsacrine 200 mg/m2 daily for three days and, concurrently, HiDAc 3 g/m2 over three hours once daily for five days. Of 20 evaluable patients with AML in relapse, there were 12 remissions; of seven additional patients with primary refractory AML, there were two remissions, and of 12 patients with ALL in relapse, there were eight remissions. The three patients with blastic phase CML and the three patients with biphenotypic leukemia did not respond. Nausea, vomiting, stomatitis, hepatic dysfunction, and diarrhea were common, but cutaneous, conjunctival, and significant cerebellar and cerebral side effects were absent. We conclude that this regimen is highly effective therapy for AML and ALL and is also safe, eliminating the major toxicities encountered with HiDAc. 相似文献
42.
John D Morris Elizabeth T Golub Shruti H Mehta Lisa P Jacobson Stephen J Gange 《AIDS research and therapy》2007,4(1):12-8
Background
Sustained use of antiretroviral therapy has been consistently shown to be one of the primary predictors of long-term effectiveness. Switching and discontinuation reflect patient and provider decisions that may limit future treatment options. In this study, we utilize data reported at semi-annual study visits from three prospective cohort studies, the AIDS Link to IntraVenous Exposure (ALIVE), the Women's Interagency HIV Study (WIHS), and the Multicenter AIDS Cohort Study (MACS), to investigate determinants of HAART modification with a particular focus on reported injection drug use (IDU). 相似文献43.
S T Traweek P L Kandalaft P Mehta H Battifora 《American journal of clinical pathology》1991,96(1):25-31
The human hematopoietic progenitor cell antigen CD34 is synthesized and expressed by early normal hematopoietic progenitor cells and by many acute leukemias. Anti-CD34 antibodies also have been reported to stain blood vessels in tissue sections, and, more recently, CD34 mRNA has been detected in vascular endothelial cells. Therefore, the authors studied the diagnostic utility of immunohistochemical CD34 antigen detection in tumors of endothelial cell derivation and compared the results with stains for von Willebrand (vW) factor. A wide variety of epithelial and mesenchymal neoplasms also were examined to assess the specificity of CD34 for vascular neoplasia. Seven cases of angiosarcoma (seven of seven), five cases of Kaposi's sarcoma (five of five), and eight cases of epithelioid hemangioendothelioma (eight of eight) were moderately to strongly positive for CD34. This reactivity was equally intense in frozen sections, alcohol-fixed tissue, and formalin-fixed specimens. In many cases, the malignant endothelial cells stained more strongly than adjacent benign endothelium. Moreover, in most cases CD34 positivity was quantitatively and qualitatively stronger than staining for vW factor. Two cases of hemangiopericytoma (two of two) were CD34 positive but stained less intensely than the angiosarcomas, Kaposi's sarcomas, or hemangioendotheliomas. Five of six cases of hemangioma also stained positively for CD34; the nonreactive tumor in this group was the only one among 28 vascular neoplasms studied that was not reactive for CD34. In comparison, 9 of the 28 vascular tumors did not stain for vW factor. Three hundred fifty-seven tumors of nonvascular derivation also were examined for CD34 antigen expression. Focal light staining was seen in one pulmonary squamous cell carcinoma; moderate to intense staining was observed in half of the epithelioid sarcomas studied (8 of 16) and in a minority of leiomyosarcomas (3 of 22). These findings indicate that CD34 is a sensitive and relatively specific marker for neoplasms of vascular origin. 相似文献
44.
M P Mehta J M Rozental A B Levin T R Mackie S S Kubsad M A Gehring T J Kinsella 《International journal of radiation oncology, biology, physics》1992,24(4):619-625
The role of stereotactic radiosurgery in the management of recurrent and newly diagnosed brain metastases was evaluated prospectively. From December 1988 to March 1991, 58 lesions in 40 patients were treated with accelerator-based stereotactic radiosurgery. All patients were followed for a minimum of 6 months or to death. The primary purpose was to determine the impact of radiosurgery on local control and its subsequent effects on quality of life. An overall tumor control rate of 82% with a complete response rate of 43% were achieved. As anticipated, the response rate for smaller tumors was substantially better than that for larger tumors (78% for lesions < 2 cm3; 50% for lesions > or = 10 cm3). Although the overall in-field progression rate was 18.5%, only 1/23 (4%) complete responders subsequently recurred. The in-field failure rate is highly comparable with recently published surgical data. Progression outside the brain was noted in two-thirds of patients. One quarter of the deaths were neurologic. The median survival for this minimally selected patient population was 6.5 months. Stereotactic radiosurgery was also associated with improved quality of life as measured by Karnofsky score, neurologic function, and steroid dependence. Long-term steroid dependence was encountered in only four patients. We conclude that stereotactic radiosurgery can be used effectively in patients with brain metastases. In this series, a high tumor response rate was achieved which was associated with improved quality of life. 相似文献
45.
46.
47.
48.
Skeletal effects of calcitonin in ovariectomized rats 总被引:3,自引:0,他引:3
T J Wronski C F Yen K W Burton R C Mehta P S Newman E E Soltis P P DeLuca 《Endocrinology》1991,129(4):2246-2250
Although calcitonin (CT) has been shown to be effective for the prevention of bone loss in early postmenopausal women, the skeletal effects of the hormone specifically during the early stages of estrogen deficiency have not been characterized histomorphometrically to date. The current study involves use of the ovariectomized (OVX) rat as an animal model for early postmenopausal bone loss to perform such a histomorphometric analysis. One group of OVX rats was injected sc with salmon CT on alternate days for a 6-week period. Additional groups of OVX and sham-operated control rats were treated with vehicle alone. In comparison to control rats, the proximal tibia of vehicle-treated OVX rats were characterized by a 3-fold decrease in cancellous bone volume and significant increases in osteoblast surface (+200%), osteoclast surface (+143%), mineralizing surface (+111%), mineral apposition rate (+36%), bone formation rate (+181%), and longitudinal bone growth (+38%). In contrast, treatment of OVX rats with CT normalized tibial cancellous bone volume and significantly decreased all of the above cellular- and fluorochrome-based indices of bone turnover to near control levels. The results indicate that CT treatment depresses bone turnover and prevents the development of osteopenia in OVX rats. These findings are consistent with the bone protective effect of CT in early postmenopausal women and further support the OVX rat as an animal model for the preclinical evaluation of prophylactic treatments for postmenopausal bone loss. 相似文献
49.
50.